Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,562 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
Yiu ZZN, Ashcroft DM, Evans I, McElhone K, Lunt M, Smith CH, Walton S, Murphy R, Reynolds NJ, Ormerod AD, Griffiths CEM, Warren RB; BADBIR Study Group. Yiu ZZN, et al. Among authors: murphy r. Br J Dermatol. 2019 Feb;180(2):329-337. doi: 10.1111/bjd.17036. Epub 2018 Oct 21. Br J Dermatol. 2019. PMID: 30070708 Free PMC article.
Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland.
Laws PM, Downs AM, Parslew R, Dever B, Smith CH, Barker JN, Moriarty B, Murphy R, Kirby B, Burden AD, McBride S, Anstey AV, O'Shea S, Ralph N, Buckley C, Griffiths CE, Warren RB. Laws PM, et al. Among authors: murphy r. Br J Dermatol. 2012 Jan;166(1):189-95. doi: 10.1111/j.1365-2133.2011.10638.x. Br J Dermatol. 2012. PMID: 21929536
Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study).
Coates LC, Aslam T, Al Balushi F, Burden AD, Burden-Teh E, Caperon AR, Cerio R, Chattopadhyay C, Chinoy H, Goodfield MJ, Kay L, Kelly S, Kirkham BW, Lovell CR, Marzo-Ortega H, McHugh N, Murphy R, Reynolds NJ, Smith CH, Stewart EJ, Warren RB, Waxman R, Wilson HE, Helliwell PS. Coates LC, et al. Among authors: murphy r. Br J Dermatol. 2013 Apr;168(4):802-7. doi: 10.1111/bjd.12190. Br J Dermatol. 2013. PMID: 23311587
Psoriatic arthritis screening tools: study design and methodologic challenges - reply from authors.
Coates LC, Aslam T, Al Balushi F, Burden AD, Burden-Teh E, Caperon AR, Cerio R, Chattopadhyay C, Chinoy H, Goodfield MJ, Kay L, Kelly S, Kirkham BW, Lovell CR, Marzo-Ortega H, McHugh N, Murphy R, Reynolds NJ, Smith CH, Stewart EJ, Warren RB, Waxman R, Wilson HE, Helliwell PS. Coates LC, et al. Among authors: murphy r. Br J Dermatol. 2014 Apr;170(4):995-6. doi: 10.1111/bjd.12824. Br J Dermatol. 2014. PMID: 24400977 No abstract available.
A U.K. multicentre audit of the assessment and management of psoriasis in children.
Lam ML, Burden-Teh E, Taibjee SM, Taylor A, Webster S, Dolman S, Jury C, Caruana D, Darne S, Carmichael A, Natarajan S, McPherson T, Moore A, Katugampola R, Kalavala M, Al-Ismail D, Richards L, Jones V, Batul Syed S, Glover M, Hughes J, Anderson E, Hughes B, Babakinejad P, Murphy R. Lam ML, et al. Among authors: murphy r. Br J Dermatol. 2015 Mar;172(3):789-92. doi: 10.1111/bjd.13471. Epub 2015 Feb 8. Br J Dermatol. 2015. PMID: 25308153 No abstract available.
How are we using systemic drugs to treat psoriasis in children? An insight into current clinical U.K. practice.
Burden-Teh E, Lam ML, Taibjee SM, Taylor A, Webster S, Dolman S, Jury C, Caruana D, Darne S, Carmichael A, Natarajan S, McPherson T, Moore A, Katugampola R, Kalavala M, Al-Ismail D, Richards L, Jones V, Batul Syed S, Glover M, Hughes J, Anderson E, Hughes B, Helbling I, Murphy R. Burden-Teh E, et al. Among authors: murphy r. Br J Dermatol. 2015 Aug;173(2):614-8. doi: 10.1111/bjd.13671. Epub 2015 Jun 21. Br J Dermatol. 2015. PMID: 25601323 No abstract available.
A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial.
Chalmers JR, Wojnarowska F, Kirtschig G, Nunn AJ, Bratton DJ, Mason J, Foster KA, Whitham D, Williams HC; BLISTER study group. Chalmers JR, et al. Br J Dermatol. 2015 Jul;173(1):227-34. doi: 10.1111/bjd.13729. Epub 2015 May 26. Br J Dermatol. 2015. PMID: 25683592 Clinical Trial.
The epidemiology of childhood psoriasis: a scoping review.
Burden-Teh E, Thomas KS, Ratib S, Grindlay D, Adaji E, Murphy R. Burden-Teh E, et al. Among authors: murphy r. Br J Dermatol. 2016 Jun;174(6):1242-57. doi: 10.1111/bjd.14507. Epub 2016 May 22. Br J Dermatol. 2016. PMID: 26928555 Review.
4,562 results